ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "genomics"

  • Abstract Number: 894 • 2012 ACR/ARHP Annual Meeting

    Genetic Variants in the IL-4 and IL-4 Receptor Genes in Association with the Severity of Joint Damage in Rheumatoid Arthritis: A Study in Seven Cohorts

    A. Krabben1, A. G. Wilson2, R. Knevel1, A. Zhernakova3, E. Brouwer3, E. Lindqvist4, T. Saxne4, G. Stoeken-Rijsbergen1, J. A. B. van Nies1, D. P. C. de Rooy1, T.W.J. Huizinga1, B. P. C. Koeleman5, R. E. M. Toes1, P. K. Gregersen6 and A. H. M. van der Helm-van Mil1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Infection & Immunity, University of Sheffield, Sheffield, United Kingdom, 3Rheumatology and Clinical Immunology, University of Groningen, University Medical Center, Groningen, Netherlands, 4Rheumatology, Lund University, Lund, Sweden, 5Medical Genetics, University Medical Center Utrecht, Utrecht, Netherlands, 6Genomics and Human Genetics, Feinstein Institute Medical Research and North Shore-Long Island Jewish Health System, Manhasset, NY

    Background/Purpose: The severity of RA is reflected by the severity of radiological joint destruction. It is highly variable between patients and up to 58% of…
  • Abstract Number: 1683 • 2012 ACR/ARHP Annual Meeting

    Associations Between Lipid and Rheumatoid Arthritis Genetic Factors, and Low Density Lipoprotein Levels in RA Patients

    Katherine P. Liao1, Dorothee Diogo2, Tianxi Cai3, Jing Cui4, Raul N. Guzman P.5, Vivian Gainer5, Shawn N. Murphy5, Susanne Churchill6, Isaac Kohane7, Elizabeth W. Karlson1 and Robert M. Plenge8, 1Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 2Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3Biostatistics, Harvard School of Public Health, Boston, MA, 4Department of Medicine, Division of Rheumatology, Immunology and Allergy, Brigham and Women's Hospital, Boston, MA, 5Research Computing, Partners Healthcare Systems, Boston, MA, 6Information Systems, Partners Healthcare Systems, Boston, MA, 7Medicine, Brigham and Women's Hospital, Boston, MA, 8Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA

    Associations between lipid and rheumatoid arthritis genetic factors, and low density lipoprotein levels in RA patientsBackground/Purpose: In epidemiologic studies, low density lipoprotein (LDL), a major…
  • Abstract Number: 729 • 2012 ACR/ARHP Annual Meeting

    Apolipoprotein L1 Risk Variants Underlie Racial Disparities in Lupus Nephritis-Induced End-Stage Renal Disease

    Robert P. Kimberly1, Barry I. Freedman2, Carl D. Langfeld3, Devin Absher4, Kelly K. Andringa1, Daniel Birmingham5, Elizabeth E. Brown6, Mary E. Comeau7, Karen H. Costenbader8, Lindsey A. Criswell9, Jeffrey C. Edberg10, John B. Harley11, Judith A. James12, Diane L. Kamen13, Joan T. Merrill14, Timothy B. Niewold15, Neha Patel16, Michelle Petri17, Rosalind Ramsey-Goldman18, Jane E. Salmon19, Mark Segal20, Kathy Moser Sivils12, Betty P. Tsao21, Bruce A. Julian1 and Lupus Nephritis-ESRD Consortium22, 1Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 2Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Biostatistics, Wake Forest University Health Sciences, Winston-Salem, NC, 4HudsonAlpha Institute for Biotechnology, Huntsville, AL, 5Medicine, Ohio State University Medical Center, Columbus, OH, 6University of Alabama at Birmingham, Birmingham, AL, 7Wake Forest University Health Sciences, Winston-Salem, NC, 8Rheumatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 9Department of Medicine, University of California, San Francisco, Rosalind Russell Medical Research Center for Arthritis, San Francisco, CA, 10Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 11Division of Rheumatology and The Center for Autoimmune Genomics & Etiology, University of Cincinnati, Cincinnati Children's Hospital Medical Center; US Department of Veterans Affairs Medical Center, Cincinnati, OH, 12Oklahoma Medical Research Foundation, Oklahoma City, OK, 13Department of Medicine, Arthritis & Clinical Immunology Program, Oklahoma Medical Research Foundation, Charleston, SC, 14Clinical Pharmacology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 15Section of Rheumatology and Gwen Knapp Center for Lupus and Immunology Research, University of Chicago, Chicago, IL, 16Rheumatology, SUNY Downstate Medical Center, Brooklyn, NY, 17Johns Hopkins University School of Medicine, Baltimore, MD, 18Medicine/Rheumatology, Northwestern University Feinberg School of Medicine, Chicago, IL, 19Rheumatology, Hospital for Special Surgery, New York, NY, 20Medicine/Nephrology, University of Florida, Gainesville, FL, 21Medicine/Rheumatology, UCLA School of Medicine, Los Angeles, CA, 22Medicine, Birmingham, AL

    Background/Purpose: The G1 and G2 coding variants in the apolipoprotein L1 gene (APOL1;  G1: a compound missense allele (glycine-342/methionine-384) and G2: an in-frame deletion (deletion…
  • Abstract Number: 1630 • 2012 ACR/ARHP Annual Meeting

    Genetic Variants of Serum Uric Acid and Gout: An Analysis of > 170,000 Individuals

    Hyon Choi1, Robert M. Plenge2, Anna Köttgen3, Veronique Vitart4, Murielle Bochud5, Christian Gieger6, Mark Caulfield7, Marina Ciullo8, Eva Albrecht6, Alexander Teumer9, Gary Curhan10, Jan Krumsiek11, Conall O'Seaghdha12, Caroline Fox13 and The Global Urate Genetics Consortium (GUGC)14, 1Section of Rheumatology and the Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA, 2Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 3Renal Division, Freiburg University Hospital, Freiburg, Germany, 4Institute of Genetics and Molecular Medicine, Western General Hospital, Edinburgh, United Kingdom, 5Institute of Social and Preventive Medicine (IUMSP), Lausanne University Hospital, Switzerland, 6German Research Center for Environmental Health, Neuherberg, Germany, 7William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom, 8Institute of Genetics and Biophysics, "A. Buzzati-Traverso", Italy, 9Interfaculty Institute for Genetics and Functional Genomics, Ernst-Moritz-Arndt- University Greifswald, Greifswald, Germany, 10German Research Center for Environmental Health, Harvard Medical School, Boston, MA, 11Institute of Bioinformatics and Systems Biology, German Research Center for Environmental Health, Neuherberg, Germany, 12German Research Center for Environmental Health, NHLBI's Framingham Heart Study and Center for Population Studies,, Neuherberg, 13Institute of Genetics and Biophysics, NHLBI's Framingham Heart Study and Center for Population Studies, Framingham, MA, 14Section of Rheumatology and the Clinical Epidemiology Unit, Boston University of School of Medicine, Boston, MA

    Background/Purpose:  Gout is a common and excruciatingly painful inflammatory arthritis caused by hyperuricemia.  In addition to various lifestyle risk factors, a substantial genetic predisposition to…
  • Abstract Number: 660 • 2012 ACR/ARHP Annual Meeting

    Abnormal Neutrophil Development in Human Systemic Lupus Erythematosus

    Namrata Singh1, Mariana J. Kaplan2, Philip L. Cohen3 and Michael F. Denny3, 1Internal Medicine, Temple University, Philadelphia, PA, 2Systemic Autoimmunity Branch, National Institutes of Health/NIAMS, Bethesda, MD, 3Rheumatology, Temple University, Philadelphia, PA

    Background/Purpose: Recent research has increased the appreciation of the contributions of neutrophils to systemic lupus erythematosus (SLE).  An abnormal circulating pool of granulocytes has been…
  • Abstract Number: 1475 • 2012 ACR/ARHP Annual Meeting

    Does Skin Gene Expression Profile Predict Response to Imatinib?

    Shervin Assassi1, Jeffrey T. Chang2, Dinesh Khanna3, Xiaochun Liu1, Daniel Furst4 and Maureen D. Mayes5, 1Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX, 2University of Texas Health Science Center at Houston, Houston, TX, 3Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 4David Geffen School of Medicine, Div of Rheumatology, University of California at Los Angeles, Los Angeles, CA, 5Internal Medicine/Rheumatology, Univ of Texas Health Science Center at Houston, Houston, TX

    Background/Purpose: Imatinib is a potent inhibitor of TGF-β signaling. Furthermore, a subgroup of SSc patients shows a prominent TGF-β gene expression signature in skin biopsy…
  • Abstract Number: 522 • 2012 ACR/ARHP Annual Meeting

    Genetic Variation in the NCR3 Locus Is Associated with Anti-SSA⁄SSB Positive Primary Sjögren′s Syndrome in Scandinavian Samples

    Gunnel Nordmark1, Maija-Leena Eloranta1, Per Eriksson2, Elke Theander3, Helena Forsblad-d'Elia4, Roald Omdal5, Marie Wahren-Herlenius6, Roland Jonsson7 and Lars Rönnblom1, 1Rheumatology, Department of Medical Sciences, Uppsala University, Uppsala, Sweden, 2Rheumatology/AIR, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden, 3Dept of Rheumatology, Skane University Hospital, Lund University, Malmö, Sweden, 4Department of Rheumatology and Inflammation Research, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden, 5Department of Internal Medicine, Stavanger university Hospital, Stavanger, Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, 6Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 7Broegelmann Research Laboratory, the Gade Institute, University of Bergen, Bergen, Norway

    Background/Purpose: Candidate gene studies in primary Sjögren’s syndrome (pSS) have identified polymorphisms in genes involved in the type I interferon (IFN) system and the type…
  • Abstract Number: 1180 • 2012 ACR/ARHP Annual Meeting

    The Sex-Determining Region Y Box 6 Locus: Shared Genetic Susceptibility Between Rheumatoid Arthritis and Psychotic Disorder

    Tony R. Merriman1, Nicola Dalbeth2, Andrew Harrison3, John Highton4, Lisa K. Stamp5, Malcolm D. Smith6, Benedicte A. Lie7, Tore K. Kvien8, Timothy Radstake9, Marieke J.H. Coenen10, Barbara Franke11, Jasper Broen12, Piet Van Riel13, Pilar Barrera14, Sophia Steer15, Marilyn E. Merriman1, Amanda Phipps-Green1, Ruth Topless1, Mansour Zamanpoor16 and Wan Rohani Wan Tain17, 1Department of Biochemistry, University of Otago, Dunedin, New Zealand, 2Medicine, University of Auckland, Auckland, New Zealand, 3Rheumatology Unit, Hutt Hospital, Lower Hutt, New Zealand, 4Dept of Medicine, Univ of Otago Med Sch, Dunedin, New Zealand, 5Department of Medicine, University of Otago, Christchurch, Christchurch, New Zealand, 6Rheumatology Research Unit, Rheumatologist, Adelaide, Australia, 7Department of Medical Genetics, University of Oslo and Oslo University Hospital, Oslo, Norway, 8Dept. of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 9Rheumatology, Radboud University Nijmegen Medical Centre, University Medical Center Utrecht, Nijmegen, Utrecht, Netherlands, 10Human Genetics (855), Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 11Human Genetics (855), Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 12Department of Rheumatology & Clinical Immunology, University Medical Center, Utrecht, Netherlands, 13Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 14Rheumatology, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 151 Sloane Ct East Flat 7, London, United Kingdom, 16University of Otago, Dunedin, New Zealand, 17Human Genome Center, School of Medical Sciences, Universiti Sains Malaysia, Malaysia

    Background/Purpose: Rheumatoid arthritis (RA) is a common autoimmune disease and schizophrenia (SZ) is a common psychotic disorder. There is an established negative association between RA…
  • Abstract Number: 433 • 2012 ACR/ARHP Annual Meeting

    Genome Wide Association Analysis of Pain Reduction in Rheumatoid Arthritis Patients Treated with Anti-TNF Medication. Results of the DREAM and Danbio Registries

    Marieke J.H. Coenen1, Masha Umicevic-Mirkov2, Hans Scheffer2, Sophine B. Krintel3, Sita H. Vermeulen4, Julia S. Johansen3, Wietske Kievit5, Mart A.F.J. van de Laar6, Piet L.C.M. van Riel5, Barbara Franke2 and Merete L. Hetland7, 1Human Genetics (855), Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 2Human Genetics (855), Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 3DANBIO and Department of Rheumatology, Copenhagen University Hospital at Glostrup, Glostrup, Denmark, 4Human Genetics and Epidemiology, Biostatistics and HTA, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 5Department of Rheumatology and DREAM registry, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, 6Department of Rheumatology and DREAM registry, Medisch Spectrum Twente & Twente University, Enschede, Netherlands, 7Copenhagen University Hospital Glostrup, Copenhagen, Denmark

    Background/Purpose: Patients with rheumatoid arthritis (RA)  rate pain relief as the highest priority in treatment outcome, and tumor necrosis factor inhibitors (anti-TNF) have proven very…
  • Abstract Number: 996 • 2012 ACR/ARHP Annual Meeting

    Genetic Predictors of Methotrexate Efficacy and Toxicity in Early Rheumatoid Arthritis: Results From the Treatment of Early Aggressive Rheumatoid Arthritis Trial

    Stella Aslibekyan1, Elizabeth Brown2, Richard J. Reynolds3, David T. Redden4, Sarah L. Morgan5, Joseph Baggott1, Jin Sha1, Larry W. Moreland6, James R. O'Dell7, Jeffrey R. Curtis8, S. Louis Bridges Jr.9 and Donna K. Arnett1, 1University of Alabama at Birmingham, Birmingham, AL, 2Univ of Alabama at Birmingham, Birmingham, AL, Birmingham, AL, 3Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 5University of Alabama Birmingham, Birmingham, AL, 6Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 7Dept of Internal Medicine, Univ of Nebraska Med Ctr, Omaha, NE, 8Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL, 9Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Methotrexate (MTX) has emerged as first-line therapy for early moderate to severe rheumatoid arthritis (RA), but individual variation in treatment efficacy and toxicity remains…
  • Abstract Number: 424 • 2012 ACR/ARHP Annual Meeting

    Influence of Pregnancy On Disease Activity-Associated Genes in Rheumatoid Arthritis

    Erik J. Peterson1, Shreyasee Amin2, Hatice Bilgic3, Emily Baechler Gillespie3, Jane E. Salmon4, Ann M. Reed5, Weihua Guan6 and Daniel L. Mueller1, 1Medicine/Rheumatic and Autoimmune Diseases, University of Minnesota Medical School, Minneapolis, MN, 2Division of Rheumatology, Mayo Clinic, Rochester, MN, 3University of Minnesota Medical School, Minneapolis, MN, 4Rheumatology, Hospital for Special Surgery, New York, NY, 5Rheumatology, Mayo Clinic, Rochester, MN, 6University of Minnesota School of Public Health, Minneapolis, MN

    Background/Purpose: Rheumatoid arthritis (RA) disease activity can often quiesce during pregnancy. Nevertheless, most women will experience a disease flare postpartum (PP). We hypothesized that changes…
  • Abstract Number: 997 • 2012 ACR/ARHP Annual Meeting

    Evidence of Novel Genetic Predictors of Methotrexate Efficacy in Rheumatoid Arthritis

    Stella Aslibekyan1, Maria I. Danila2, Jin Sha1, David T. Redden3, Richard J. Reynolds4, Elizabeth Brown5, Laura B. Hughes6, Molly S. Bray1, Sarah L. Morgan7, Larry W. Moreland8, James R. O'Dell9, Jeffrey R. Curtis10, Robert P. Kimberly11, Lindsey A. Criswell12, Robert M. Plenge13, S. Louis Bridges Jr.14 and Donna K. Arnett1, 1University of Alabama at Birmingham, Birmingham, AL, 2Med/Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 3Biostatistics, University of Alabama at Birmingham, Birmingham, AL, 4Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 5Univ of Alabama at Birmingham, Birmingham, AL, Birmingham, AL, 6Med Div of Clin Imm & Rheum, University of Alabama at Birmingham, Birmingham, AL, 7University of Alabama Birmingham, Birmingham, AL, 8Division of Rheumatology & Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 9Dept of Internal Medicine, Univ of Nebraska Med Ctr, Omaha, NE, 10Rheumatology & Immunology, Univ of Alabama-Birmingham, Birmingham, AL, 11Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 12Department of Medicine, University of California, San Francisco, Rosalind Russell Medical Research Center for Arthritis, San Francisco, CA, 13Division of Rheumatology, Immunology and Allergy and Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, 14Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Methotrexate (MTX), a disease-modifying anti-rheumatic drug used as first-line therapy in rheumatoid arthritis (RA), is characterized by considerable heterogeneity in individual treatment response. We…
  • Abstract Number: 409 • 2012 ACR/ARHP Annual Meeting

    Pathway Analysis of Genome-Wide Association Studies On Rheumatoid Arthritis

    Young Ho Lee1, Sung Jae Choi2, Jong Dae Ji2 and Gwan Gyu Song3, 1Internal Medicine, Rheumatology, Korea University Medical Center, Seoul, South Korea, 2Rheumatology, Korea University Medical Center, Seoul, South Korea, 3Div of Rheum, Dept of Int Med, Korea Univ College of Med, Seoul, South Korea

    Background/Purpose: Genome-wide association studies (GWASs) have been successfully used to identify novel common genetic variants that contribute to susceptibility to complex diseases, but individual GWASs…
  • Abstract Number: 998 • 2012 ACR/ARHP Annual Meeting

    Association Study of Genetic Risk Variants for Psoriasis in a Large Cohort of Psoriatic Arthritis, Psoriasis and Controls of the Spanish Population and Association with Relevant Clinical Subphenotypes

    J. D. Cañete1, Jose Luis Fernandez-Sueiro2, Raimon Sanmarti3, Jesus Rodriguez4, Jordi Gratacós5, Rubén Queiro6, Juan Carlos Torre-Alonso7, Jose Perez Venegas8, Santiago Muñoz-Fernandez9, Carlos Gonzalez10, Carlos Montilla11, Daniel Roig12, Alba Erra13, Isabel Acosta14, Antonio Fernández-Nebro15, Pedro Zarco16, Arnald Alonso17, María América López-Lasanta17, Antonio Julià17, Raül Tortosa17 and Sara Marsal18, 1Unitat d'Artritis, Servei de Reumatologia, Hospital Clínic de Barcelona,, Barcelona, Spain, 2Rheumatology Service, Complejo Hospitalario Universitario La Coruña, La Coruña, Spain, 3Rheumatology Service, Hospital Clínic of Barcelona, Barcelona, Spain, 4Rheumatology, Hospital Universitari de Bellvitge, Barcelona, Spain, 5Rheumatology Service, Hospital Parc Taulí, Sabadell (Barcelona), 6Rheumatology Service, Hospital Universitario Central de Asturias, Oviedo, Spain, 7Rheumatology Service, Hospital Monte Naranco, Oviedo, Spain, 8Rheumatology Service, Hospital del SAS de Jerez de la Frontera, Jerez De La Frontera, Spain, 9Rheumatology Service, Hospital Infanta Sofía, Madrid, Spain, 10Rheumatology Service, Hospital Gregorio Marañon, Madrid, Spain, 11Unit Rheumatology, Hospital Universitario de Salamanca, Salamanca, Spain, 12Rheumatology Service, Hospital Universitari de Bellvitge, Hospitalet de Llobregat- Barcelona, Spain, 13Rheumatology Service, Hospital San Rafael, Barcelona, Spain, 14Rheumatology Service, Hospital Universitari Vall d'Hebron, Barcelona, Spain, 15Rheumatology Service, Hospital Regional Universitario Carlos Haya, Málaga, Spain, 16Rheumatology Service, Fundación Hospital Alcorcon, Alcorcon, Madrid, Spain, 17Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain, 18Rheumatology, University Hospital Vall d'Hebron, Barcelona, Spain

    Background/Purpose: Psoriatic Arthritis (PsA) is a complex disease with a substantial genetic risk component (first-degree relative risk ~ 55). Recently, Genomewide Association Studies (GWAS) have…
  • Abstract Number: 313 • 2012 ACR/ARHP Annual Meeting

    Epigenetic Changes in Fibrosis and Myocyte Repair Genes May Contribute to Pathogenesis in Monozygotic Twins Discordant for Cardiac Manifestations of Neonatal Lupus

    Paula S. Ramos1, Timothy D. Howard2, Miranda C. Marion3, Satria Sajuthi4, Robert M. Clancy5, Jill P. Buyon6 and Carl D. Langefeld4, 1Department of Medicine, Medical University of South Carolina, Charleston, SC, 2Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, 3Department of Biostatistical Sciences, Wake Forest University Health Sciences, Winston-Salem, NC, 4Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, 5Medicine, New York University School of Medicine, New York, NY, 6Department of Medicine, New York University School of Medicine, New York, NY

    Background/Purpose: Cardiac manifestations of neonatal lupus (cardiac-NL) which comprise conduction defects and cardiomyopathy, occur in fetuses exposed to maternal anti-Ro antibodies and carry a case…
  • « Previous Page
  • 1
  • …
  • 12
  • 13
  • 14
  • 15
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology